期刊文献+

伊班膦酸钠对人肺巨细胞癌高转移株PLA-801D体外生长的抑制作用 被引量:3

Inhibitory effect of ibandronate on the growth of lung cancer cell line PLA-801D in vitro
下载PDF
导出
摘要 目的研究伊班膦酸钠(IBN)对体外培养的人肺巨细胞癌高转移株PLA-801D细胞生长增殖的影响及其潜在的作用机制。方法采用MTT法检测不同浓度IBN、及相同浓度不同作用时间的IBN对PLA-801D细胞系生长增殖的影响,应用流式细胞仪检测不同浓度IBN作用下,PLA-801D细胞周期的变化。结果在10~100μg/ml的浓度范围内,IBN对PLA-801D细胞生长增殖均有抑制作用(P<0.01),抑制效果与IBN的药物浓度和作用时间呈正相关(r药物浓度=0.987,r作用时间=0.985);IBN可使细胞明显阻滞于S期,G2/M期细胞比例则明显减少。结论在10~100μg/ml的浓度范围内,IBN对体外生长的PLA-801D细胞的抑制作用呈剂量、时间依赖性,其机制可能与其将细胞阻滞在DNA合成期(S期),阻碍肿瘤细胞分裂增殖有关。 Objective To study the inhibitory effect of ibandronate (IBN) on the growth of lung cancer cell line PLA-801D in vitro, and the mechanism of such effect was studied. Methods The effects of different doses or treatment time of IBN on the growth of PLA-801D cell line were detected by MTT method. The mechanism of the effect was analyzed by the examination of cell cycle using flow cytometry. Remits With the concentration of 10 to 100 μg/ml, IBN obviously inhibited the growth of PLA-801D cell (P〈0. 01) in dose- and time-dependent manner (r concentration =0. 987, r treatment time =0. 985), and blocked the cellular cycle at the S/G2 boundary. Conclusion With the concentration 10 to 100μg/ml, IBN can inhibit the growth of lung cancer cell line in dose- and time-dependent manner. Its mechanism probably relates to blockage of cell cycle at S phase.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2007年第4期352-354,共3页 Medical Journal of Chinese People's Liberation Army
关键词 伊班膦酸钠 双膦酸盐 肺肿瘤 细胞周期 ibandronate bisphosphonate lung neoplasms cell cycle
  • 相关文献

参考文献10

  • 1Coleman RE.Metastatic bone disease:clinical features,pathophysiology and treatment strategies.Cancer Treat Rev,2001,27(3):165 被引量:1
  • 2Ross JR,Saunders Y,Edmonds PM,et al.Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer.BMJ,2003,327(7413):469 被引量:1
  • 3Lee MV,Fong EM,Singer FR,et al.Bisphosphonate treatment inhibits the growth of prostate cancer cells.Cancer Res,2001,61(6):2602 被引量:1
  • 4Sonnemann J,Eckervogt V,Truckenbrod B,et al.The bisphosphonate pamidronate is a potent inhibitor of human osteosarcoma cell growth in vitro.Anticancer Drug,2001,12(5):459 被引量:1
  • 5Coleman R,Gralow J,Bell R,et al.Zoledronic acid is being investigated for the prevention of bone metastases in patients with early stage cancer.Seventh Workshop on Bisphosphonates-From the Laboratory to the Patient.What is New in isphosphonates? March 24-26,2004,Davos,Switzerland,Poster 66 被引量:1
  • 6Fleisch H.Development of bisphosphonates.Breast Cancer Res,2002,4(1):30 被引量:1
  • 7Rogers MJ,Gordon S,Benford HL,et al.Cellular and molecular mechanisms of axtion of bisphosphonates.Cancer,2000,88(12 Suppl):2961 被引量:1
  • 8Kubista B,Trieb K,Sevelda F,et al.Anticancer effects of zoledronic acid against human osteosarcoma cells.J Orthop Res,2006,24(6):1145 被引量:1
  • 9Jagdev SP,Coleman RE,Shipman CM,et al.The bisphosphonate,zoledronic acid,induces apoptosis of breast cancer cells:evidence for synergy with paclitaxel.Br J Cancer,2001,84:1126 被引量:1
  • 10Caraglia M,Santini D,Marra M,et al.Emerging anti-cancer molecular mechanisms of aminobisphosphonates.Endocr Relat Cancer,2006,13(1):7 被引量:1

同被引文献34

  • 1戴广海,吴志勇,石燕,焦顺昌,魏秀芳.伊班膦酸钠对人乳腺癌细胞系MDA-MB-231、MDA-MB-453的体外生长抑制作用[J].现代肿瘤医学,2007,15(6):744-747. 被引量:5
  • 2何贤峰,杨述华,傅德皓,刘家国,胡勇,何宇,王庆德.唑来膦酸对骨肉瘤细胞增殖凋亡和VEGF表达的影响[J].中国癌症杂志,2007,17(7):531-535. 被引量:5
  • 3Senaratne SG,Pirianov G,Mansi JL,et al.Bisphosphonates induce apoptosis in human breast cancer cell lines[J].Br J Cancer,2000; 82(8):1459-68. 被引量:1
  • 4Lee MV,Fong EM,Singer FR,et al.Bisphosphonate treatment inhibits the growth of prostate cancer cells [J].Cancer Res,2001 ;61(6):2602-8. 被引量:1
  • 5Sonnemann J,Eckervogt V,Truckenbred B,et al.The bisphosphonate pamidronate is a potent inhibitor of human osteosarcoma cell growth in vitro [J].Anticancer Drug,2001 ;12:450-65. 被引量:1
  • 6Kubista B,Trieb K,Sevelda F,et al.Anticancer effects of zoledronic acid against human osteosarcoma cells [J].J Orthop Res,2006;24(6):1145-52. 被引量:1
  • 7Russell RG, Rogers MJ. Bisphosphonates: from the laboratory to the clinic and back again[J]. Bone, 1999, 25(1): 97-106. 被引量:1
  • 8Dunford JE, Thompson K, Coxon FP, et al. Struacture-activity relationships for inhibition of farnesyl cliphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates[J]. Pharmacol Exp Ther, 2001, 296(2): 235-242. 被引量:1
  • 9Sanfini D, Vespasiani Gentilucd U, Vincenzi B, et al. The antineoplastic role of bisphosphonates: from basic research to clinical evidence[J]. Ann Oncol, 2003, 14(10): 1468-1476. 被引量:1
  • 10Senarame SG, MansiJL, Colston KW. The bisphosphonate zoledronic acid impairs Ras membrane (correction of impairs membrane) localisation and induces cytochrome c release in breast cancer cells[J]. BrJ Cancer, 2002, 86(9): 1479-1486. 被引量:1

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部